Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.
Juan P RodrigoMario Sánchez-CanteliMaría Otero-RosalesPablo Martínez-CamblorFrancisco Hermida-PradoJuana M García-PedreroPublished in: Journal of translational medicine (2024)
This is the first meta-analysis to demonstrate a higher response and clinical benefit from ICI therapy in HNSCC patients with high TMB.